Cargando…
Advances in Adoptive Cell Therapy Using Induced Pluripotent Stem Cell-Derived T Cells
Adoptive cell therapy (ACT) using chimeric antigen receptor (CAR) T cells holds impressive clinical outcomes especially in patients who are refractory to other kinds of therapy. However, many challenges hinder its clinical applications. For example, patients who undergo chemotherapy usually have an...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505955/ https://www.ncbi.nlm.nih.gov/pubmed/34650571 http://dx.doi.org/10.3389/fimmu.2021.759558 |